Key result
Maternal diabetes linked to ~16 ms greater fetal RV dyssynchrony versus controls.
Why the study?
This study aimed to evaluate dyssynchronous heart failure in fetuses of mothers with diabetes mellitus compared to fetal controls using 2D speckle tracking echocardiography and novel M-mode prototype software.
Does maternal diabetes mellitus cause dyssynchronous heart failure in fetuses as evaluated by 2D-STE and novel M-mode software?
Cohort (n=174)
Does maternal diabetes mellitus cause dyssynchronous heart failure in fetuses as evaluated by 2D-STE and novel M-mode software?
Maternal diabetes mellitus is associated with increased intraventricular dyssynchrony in fetal hearts, which can be accurately identified using a novel M-mode prototype software.
Maternal diabetes associated with fetal RV dyssynchrony; hypothesis-generating and requires prospective outcome studies before any clinical adoption.
OBJECTIVES: This study aimed to investigate dyssynchronous heart failure in fetuses of mothers with diabetes mellitus (FDM) and fetal controls (FC) using two-dimensional speckle tracking echocardiography (2D-STE) and novel M-mode prototype software (PS). METHODS: In this cohort study 174 fetuses were analyzed, 87 in the FDM-cohort and 87 gestational age-matched fetuses in the FC-cohort. A subgroup of 38 fetuses formed the final case group, with a high median frame rate of approximately 160 frames/s. Using 2D Cardiac Performance Analysis software (TOMTEC, Unterschleissheim, Germany) we measured global longitudinal strain (GLS). TOMTEC PS detected annular displacement by assessing an artificial M-mode on the previously generated tracking. Dyssynchrony (DYS) was calculated as the inter- and intraventricular difference in time to peak GLS or annular displacement. RESULTS: Greater DYS was observed in all basal myocardial measurement sites and software between FDM-cohort compared to FC-cohort and no significant correlation was found between DYS measurements and gestational age. Intraventricular DYS between the basal segments was statistically significant (all p ≤ 0.036, Wald test of univariate regression models). The PS performed best in DYS measurements identifying right ventricular DYS as potentially predicting FDM (FDM: median, 18.5 (interquartile range [IQR], 13.9-25.0) ms vs. FC: median, 2.7 [IQR, 1.5-3.5] ms; p < 0.001). CONCLUSION: Increased intraventricular DYS demonstrated an impact of maternal diabetes mellitus on fetal hearts independent of gestational age. The prototype M-mode method identified cardiac dysfunction with higher accuracy than the conventional analysis. High-quality echocardiographic image acquisition is imperative for clinical application of 2D-STE and related advanced technologies.
No takes yet. Share an insight, caveat, or question.
Kühle et al. (2024) conducted a cohort in Fetal heart failure in maternal diabetes (n=174). Maternal diabetes mellitus vs. Fetal controls was evaluated on Right ventricular dyssynchrony (DYS) measured by prototype software (p=< 0.001). Fetuses of mothers with diabetes mellitus exhibited significantly greater right ventricular dyssynchrony compared to controls (median 18.5 ms vs 2.7 ms; p<0.001) using novel M-mode software.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: